Yibai Pharmaceutical: Loss of 1990.21 million yuan in the first half of the year.

Yibai Pharmaceutical disclosed its interim report for the first half of 2025 on the evening of August 20th. The company achieved operating income of 993 million yuan in the first half of the year, a year-on-year decrease of 14.99%; the net profit attributable to the parent company was a loss of 19.9021 million yuan, compared to a loss of 106 million yuan in the same period last year. During the reporting period, the company's main product sales decreased, but the amount of costs and expenses still exceeded the amount of income; compared with the same period last year, due to the company's strengthened expense control and cost reduction efforts, the decrease in costs and expenses was greater than the decrease in income, leading to a reduction in losses for this period.